- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Blood
Clinical Trial Search
Trial Protocol ID
XPORT-MF-044
Investigator
Mohit Narang, M.D.
A Phase 2 study to evaluate the efficacy and safety of selinexor monotherapy in subjects with JAK inhibitor (JAKi)-naïve myelofibrosis and moderate thrombocytopenia
Trial Protocol ID
SENTRY_XPORT-MF-034
Investigator
Mohit Narang, M.D.
A Phase 1/3 Study to Evaluate Efficacy and Safety of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Ruxolitinib in Treatment-naïve Patients With Myelofibrosis
Trial Protocol ID
AIS-D04_RUBY-4
Investigator
Mohit Narang, M.D.
A Phase 1b, Open-Label Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Povetacicept in Subjects with Autoimmune Cytopenias (RUBY-4)
Trial Protocol ID
USOR 23046_CVAY736Q12201_TPO_RA *STAR*
A phase 2 study to evaluate the efficacy and safety of ianalumab (VAY736) in patients with primary immune thrombocytopenia (ITP) previously treated with at least a corticosteroid and a thrombopoietin receptor agonist
Trial Protocol ID
USOR 18263_BGB-3111-215 *STAR*
A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated B-Cell Lymphoma Intolerant of Prior Treatment with Ibrutinib and/or Acalabrutinib
Trial Protocol ID
USOR 22244_IM048022
Investigator
Jose Méndoza, M.D.
A Phase 3, Two-stage, Randomized, Multi-center, Controlled, Open-label Study Comparing Iberdomide Maintenance to Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT) in Participants with Newly Diagnosed Multiple Myeloma (NDMM)
Trial Protocol ID
USOR 20285_IST-337
Investigator
Mohit Narang, M.D.
A phase II trial of Daratumumab, Lenalidomide and Dexamethasone (DRd) in combination with Selinexor for patients with newly diagnosed multiple myeloma
Trial Protocol ID
USOR 21367_GRAIL-012
Investigator
Jason Taksey, M.D.
The PATHFINDER 2 Study: Evaluating the Safety and Performance of the GRAIL Multi-Cancer Early Detection Test in an Eligible Screening Population
Trial Protocol ID
AZA-MDS-006
Investigator
Mohit Narang, M.D.
Connect® Myeloid: The Myelofibrosis (MF), Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry